Zhongrun Qian
-
- MicroRNA in disease regulation 3
-
- Glioma Diagnosis and Treatment 3
-
- RNA modifications and cancer 3
- Circular RNAs in diseases 3
- Ubiquitin and proteasome pathways 2
-
- Meningioma and schwannoma management 3
-
- Peptidase Inhibition and Analysis 3
-
- interferon and immune responses 2
- Cited by
- Cancer ResearchNeurologyGenetics
- Journals
- Journal of Clinical Investigation (1 paper)JNCI Journal of the National Cancer Institute (1 paper)International Journal of Cancer (1 paper)
- Partner nations
- ChinaCanadaUnited States
In The Last Decade
Zhongrun Qian
15 papers receiving 398 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 147
- Neurology 78
- Genetics 53
- Aging 8
- Molecular Biology 246
Countries citing papers authored by Zhongrun Qian
This map shows the geographic impact of Zhongrun Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhongrun Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhongrun Qian more than expected).
Fields of papers citing papers by Zhongrun Qian
This network shows the impact of papers produced by Zhongrun Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhongrun Qian. The network helps show where Zhongrun Qian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhongrun Qian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 21 | |
| 4 | 2022 | 16 | |
| 5 | 2021 | 15 | |
| 6 | 2020 | 29 | |
| 7 | 2019 | 34 | |
| 8 | 2018 | 6 | |
| 9 | 2017 | 26 | |
| 10 | 2017 | 9 | |
| 11 | 2017 | 72 | |
| 12 | 2016 | 17 | |
| 13 | 2016 | 7 | |
| 14 | 2016 | 56 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 85 |
About Zhongrun Qian
Zhongrun Qian is a scholar working on Cancer Research, Genetics and Neurology, having authored 16 papers that have together received 402 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (3 papers), Meningioma and schwannoma management (3 papers), MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Peptidase Inhibition and Analysis (3 papers), Circular RNAs in diseases (3 papers), interferon and immune responses (2 papers) and Ubiquitin and proteasome pathways (2 papers). The work is most often cited by research in Cancer Research (147 citations), Neurology (78 citations) and Genetics (53 citations). Zhongrun Qian has collaborated with scholars based in China, Canada and United States. Frequent co-authors include Yongming Qiu, Xi Yang, Yingying Lin, Wenbin Zhang, Qi Shen, Dianxu Yang, Quanmin Nie, Gan Jiang, Xi Yang and Li Ren. Their work appears in journals such as Journal of Clinical Investigation, JNCI Journal of the National Cancer Institute and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.